Astellas Ups Offer To $4 Billion-Plus, Wins OSI Accession To Buyout
This article was originally published in PharmAsia News
Executive Summary
The latest Astellas offer in its effort to acquire U.S.-based OSI Pharmaceuticals has been accepted by the target company's board